Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alamo Biologics, formerly known as Alamo Tissue Service, is a private U.S. full-service tissue bank focused on human allografts and related biologics for surgical and regenerative applications. The company manufactures, stores, and distributes human cellular and tissue-based products for orthopedic, sports medicine, spine, trauma, dental, and reconstructive use. Its portfolio includes connective and reconstructive tissue allografts, amniotic membrane products, and demineralized bone matrix offerings. A key differentiator is its proprietary PASCO2 supercritical carbon dioxide cleaning and sterilization technology, which the company positions as a tissue-preserving alternative to irradiation. Alamo Biologics also offers research and development, custom product development, and contract manufacturing services to medical customers and partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alamo Biologics.